Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Award
Common Stock
2022-11-10$17.05/sh+82$1,398→ 96,534 total
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 82 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.